Published in Postgrad Med J on October 01, 1978
Pyrophosphate heart scan in patients with progressive systemic sclerosis. Br Heart J (1982) 0.78
A new method for radionuclide imaging of myocardial infarcts. Radiology (1974) 2.24
Technetium stannous pyrophosphate myocardial scintigrams in patients with chest pain of varying etiology. Circulation (1975) 1.87
A new method for radionuclide imaging of acute myocardial infarction in humans. Circulation (1974) 1.85
Myocardial infarction as a complication of coronary bypass surgery. Circulation (1973) 1.47
Results of direct coronary-artery surgery for the treatment of angina pectoris. N Engl J Med (1973) 1.44
Noninvasive quantitation of myocardial infarction with technetium 99m pyrophosphate. Circulation (1975) 1.19
Mitochondrial mineralization in human myocardium. Am J Clin Pathol (1970) 1.17
Morphologic correlates of technetium-99m stannous pyrophosphate imaging of acute myocardial infarcts in dogs. Circulation (1975) 1.11
Acute subendocardial myocardial infarction in patients. Its detection by Technetium 99-m stannous pyrophosphate myocardial scintigrams. Circulation (1975) 1.07
CLINICOPATHOLOGIC CORRELATIONS IN CORONARY ATHEROSCLEROSIS. FOUR HUNDRED THIRTY PATIENTS STUDIED WITH POSTMORTEM CORONARY ANGIOGRAPHY. Circulation (1963) 1.05
Improved detection of myocardial infarction with technetium-99m stannous pyrophosphate and serum MB creatine phosphokinase. Am J Cardiol (1976) 1.04
New Q waves after coronary artery bypass surgery for angina pectoris. Am J Cardiol (1974) 1.03
Unstable angina pectoris. Clinical, angiographic, and myocardial scintigraphic observations. Br Heart J (1976) 0.96
Determination of creatine kinase isoenzyme MB activity in serum using immunological inhibition of creatine kinase M subunit activity. Activity kinetics and diagnostic significance in myocardial infarction. Clin Chim Acta (1976) 0.96
Technetium 99m stannous pyrophosphate myocardial imaging in patients with and without left ventricular aneurysm. Circulation (1976) 0.93
Mechanisms contributing to myocardial accumulation of technetium-99m stannous pyrophosphate after coronary arterial occlusion. Am J Cardiol (1977) 0.91
New Q waves after aortocoronary bypass surgery. Unmasking of an old infarction. N Engl J Med (1974) 0.90
Usefulness of preoperative and postoperative Tc-99m (Sn)-pyrophosphate scans in patients with ischemic and valvular heart disease. Am J Cardiol (1977) 0.89
Technetium-99m pyrophosphate myocardial uptake in patients with stable angina pectoris. Am J Cardiol (1977) 0.88
The application of radionuclide infarct scintigraphy to diagnose perioperative myocardial infarction following revascularization. Circulation (1977) 0.87
Relationships between myocardial perfusion, myocardial necrosis, and technetium--99m pyrophosphate uptake in dogs subjected to sudden coronary occlusion. Circulation (1976) 0.84
Rubidium-81: a new myocardial scanning agent. Radiology (1974) 0.84
Evaluation of enzyme testing for the detection of myocardial infarction following direct coronary surgery. Circulation (1973) 0.83
Cesium-129 myocardial scintigraphy to detect myocardial infarction. Circulation (1973) 0.81
Myocardial imaging with Cc-99m pyrophosphate in patients on adriamycin treatment for neoplasia. J Nucl Med (1977) 0.80
Technetium-99m stannous pyrophosphate scintigrams in normal subjects, patients with exercise-induced ischemia and patients with a calcified valve. Am J Cardiol (1977) 0.79
Q waves in coronary heart disease: newer understanding of their clinical implications. Am J Cardiol (1976) 0.78
Surgical intervention for preinfarction angina. Adv Cardiol (1975) 0.78
Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet (1982) 2.51
Verapamil in the treatment of paroxysmal supraventricular tachycardia. Postgrad Med J (1974) 2.08
Effect of intravenous propranolol on QT interval. A new method of assessment. Br Heart J (1980) 1.71
Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers. Gut (1993) 1.71
Utilization of nucleoside monophosphates per Se for intraperiplasmic growth of Bdellovibrio bacteriovorus. J Bacteriol (1975) 1.64
Acute ureteric dilatation for ureteroscopy. An experimental study. Br J Urol (1988) 1.53
Radiological malformations of the ear in Pendred syndrome. Clin Radiol (1998) 1.52
Biochemical genetics of the alpha-keto acid dehydrogenase complexes of Escherichia coli K12: isolation and biochemical properties of deletion mutants. J Gen Microbiol (1977) 1.52
Detection of postinfarction left ventricular aneurysms by first pass radionuclide ventriculography using a multicrystal gamma camera. Br Heart J (1979) 1.52
Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer. Eur J Nucl Med (1993) 1.48
Pendred syndrome--100 years of underascertainment? QJM (1997) 1.45
A strategy for thyroid function tests. Br Med J (1975) 1.43
Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome. Br Heart J (1975) 1.41
Captopril renal scintigraphy in patients with hypertension and chronic renal failure. J Nucl Med (1994) 1.41
Influence of arm positioning on tomographic thallium-201 myocardial perfusion imaging and the effect of attenuation correction. Eur J Nucl Med (2000) 1.40
Comparison of 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet (1996) 1.40
Factors influencing the accuracy of renal output efficiency. Nucl Med Commun (2001) 1.40
Physical performance evaluation of the Toshiba GCA-9300A triple-headed system. J Nucl Med (1993) 1.39
The response of 99Tcm-methylene diphosphonate and 99Tcm-hexametazime-labelled neutrophils to intra-articular steroid injection in rheumatoid arthritis. Nucl Med Commun (1992) 1.38
Instantaneous lead entrapment: successful percutaneous removal using the cook workstation. Pacing Clin Electrophysiol (1998) 1.38
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab (2001) 1.37
Characterisation of ocular melanoma with cutaneous melanoma antibodies. Br J Ophthalmol (1987) 1.35
Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate. Am Heart J (1984) 1.35
Biochemical and genetic characterics of deletion and other mutant strains of Salmonella typhimurium LT2 lacking alpha-keto acid dehydrogenase complex activities,. J Gen Microbiol (1974) 1.34
Isolation and characterization of polyadenylate-containing RNA from Bacillus brevis. Biochemistry (1978) 1.33
Detection of high levels of polyadenylate-containing RNA in bacteria by the use of a single-step RNA isolation procedure. Nucleic Acids Res (1981) 1.33
Biochemical genetics of the alpha-keto acid dehydrogenase complexes of Escherichia coli K12: genetic characterization and regulatory properties of deletion mutants. J Gen Microbiol (1978) 1.32
Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man. Br Heart J (1982) 1.26
A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun (1992) 1.26
Two or more intra AV nodal pathways in association with either a James or Kent extranodal bypass in 3 patients with paroxysmal supraventricular tachycardia. Br Heart J (1973) 1.24
Effects of methotrexate on intraperiplasmic and axenic growth of Bdellovibrio bacteriovorus. J Bacteriol (1975) 1.23
Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias. Am J Cardiol (1983) 1.23
Evaluation of the efficacy of 99mTc-Infecton, a novel agent for detecting sites of infection. J Clin Pathol (1998) 1.21
Phasic abnormalities of left ventricular emptying in coronary artery disease. Br Heart J (1981) 1.21
Radionuclide evaluation pre- and postextracorporeal shock wave lithotripsy for renal calculi. J Nucl Med (1987) 1.20
Global and regional right ventricular function after acute myocardial infarction: dependence upon site of left ventricular infarction. Br Heart J (1987) 1.15
Sinus node dysfunction associated with absence of right superior vena cava. Br Heart J (1979) 1.15
Transvenous pacing lead-induced thrombosis: a series of cases with a review of the literature. Cardiology (2000) 1.15
Concealed bypasses of the atrioventricular mode in patients with paroxysmal supraventricular tachycardia revealed by intracardiac electrical stimulation and verapamil. Am J Cardiol (1974) 1.14
Emission computerised tomography. A new diagnostic imaging technique. Lancet (1978) 1.14
Electrophysiological effects of sotalol--just another beta blocker? Br Heart J (1982) 1.13
Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med (2000) 1.13
Implantable automatic scanning pacemaker for termination of supraventricular tachycardia. Am J Cardiol (1982) 1.13
The distinction between obstructive uropathy and nephropathy by radioisotope transit times. Br J Urol (1978) 1.12
Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome. Br Heart J (1974) 1.10
Biological function of gramicidin: selective inhibition of RNA polymerase. Proc Natl Acad Sci U S A (1977) 1.10
Ventricular tachycardia in 4 patients evaluated by programmed electrical stimulation of heart and treated in 2 patients by surgical division of anterior radiation of left bundle-branch. Br Heart J (1973) 1.08
Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG]. Clin Endocrinol (Oxf) (2001) 1.08
Fatal verapamil overdose. Lancet (1982) 1.07
Ocular metastases secondary to carcinoid tumors: the utility of imaging with [(123)I]meta-iodobenzylguanidine and [(111)In]DTPA pentetreotide. J Clin Endocrinol Metab (2002) 1.06
Computer-assisted blood background subtraction (CABBS) renography in obstructive nephropathy. Proc R Soc Med (1970) 1.06
Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments. Br J Ophthalmol (1987) 1.06
Temporal evolution of changes in left ventricular function induced by cold pressor stimulation. An assessment with radionuclide angiography and gold 195m. Br Heart J (1984) 1.05
Peak exercise and immediate postexercise imaging for the detection of left ventricular functional abnormalities in coronary artery disease. Am J Cardiol (1984) 1.04
Disturbed gastric and small bowel transit in severe idiopathic constipation. Dig Dis Sci (1993) 1.03
A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer. J Clin Oncol (1986) 1.03
Renin and renal autoregulation. Lancet (1968) 1.03
Ventricular preexcitation due to anomalous nodo-ventricular pathways: report of 3 patients. Eur J Cardiol (1979) 1.03
Is there a future for single photon emission tomography? Rofo (1979) 1.03
Obstructive nephropathy: successful evaluation with radionuclides. Lancet (1979) 1.02
Comparison between emission and transmission computed tomography of the liver. Br Med J (Clin Res Ed) (1981) 1.02
A new transverse-section brain imager for single-gamma emitters. J Nucl Med (1979) 1.02
Uptake of 99mTc labelled (Fab')2 fragments of monoclonal antibody 225.28S by a benign ocular naevus. Eur J Nucl Med (1988) 1.02
Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma. J Clin Oncol (2004) 1.00
A simple modification of the Salmonella liquid-incubation assay. Increased sensitivity for detecting mutagens in human urine. Mutat Res (1983) 1.00
Localization of radioiodine conjugated to the monoclonal antibody HMFG2 in human ovarian carcinoma: assessment of intravenous and intraperitoneal routes of administration. Cancer Res (1987) 1.00
The use of the radioactive renogram in the reticuloses. Br J Radiol (1969) 1.00
Xenon washout. Lancet (1971) 1.00
Retrograde invasion of the bundle branches producing aberration of the QRS complex during supraventricular tachycardia studied by programmed electrical stimulation. Circulation (1974) 0.99
In vivo leukocyte migration in arthritis. Arthritis Rheum (1991) 0.99
The in vivo distribution of 99Tcm-HM-PAO in normal man. Nucl Med Commun (1986) 0.98
Unusual causes of I-131 metaiodobenzylguanidine uptake in non-neural crest tissue. Clin Nucl Med (1991) 0.98
Is "T4 toxicosis" a normal biochemical finding in elderly women? Lancet (1975) 0.98
Specialized distributions of mitochondria and endoplasmic reticulum proteins define Ca2+ wave amplification sites in cultured astrocytes. J Neurosci Res (1998) 0.97
Differential diagnosis of adnexal masses: risk of malignancy index, ultrasonography, magnetic resonance imaging, and radioimmunoscintigraphy. Int J Gynecol Cancer (2007) 0.97
Phase analysis of the first pass radionuclide angiocardiogram. Br Heart J (1982) 0.97
Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias. Br Heart J (1980) 0.97
Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison. J Nucl Med (1987) 0.96
Disturbed gastric emptying in the short bowel syndrome. Evidence for a 'colonic brake'. Gut (1993) 0.95
A prospective study of the use of 111In-labelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake. Int J Colorectal Dis (1989) 0.95
Regular cerebral blood flow mapping with 99mTc-labelled compound. Lancet (1985) 0.95
Global and regional cerebral blood flow. Noninvasive quantitation in patients with subarachnoid hemorrhage. J Neurosurg (1980) 0.95
Detection of a false left ventricular aneurysm by first-pass radionuclide ventriculography. J Nucl Med (1979) 0.95
Comparison of the effect of linear gramicidin analogues on bacterial sporulation, membrane permeability, and ribonucleic acid polymerase. Biochemistry (1979) 0.95
Surgical treatment of ventricular tachycardia after epicardial mapping studies. Br Heart J (1975) 0.95
Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders. J Nucl Med (1988) 0.94
Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodies. Br J Cancer (1982) 0.94
Cryothermal mapping and cryoablation in the treatment of refractory cardiac arrhythmias. Circulation (1980) 0.94
Ebstein's anomaly in association with anomalous nodoventricular conduction. Pre-operative and intra-operative electrophysiological studies. J Electrocardiol (1979) 0.94
The long QT syndrome; effects of drugs and left stellate ganglion block. Am Heart J (1982) 0.94
Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351). J Nucl Med (1997) 0.93
The design of a two-phase radiolabelled meal for gastric emptying studies. Nucl Med Commun (1991) 0.93
The use of 99mTc-MIBI scanning in multiple myeloma. Br J Cancer (1996) 0.93
UK audit and analysis of quantitative parameters obtained from gamma camera renography. Nucl Med Commun (2001) 0.92
The clinical validation of gold-195m: a new short half-life radiopharmaceutical for rapid, sequential, first pass angiocardiography in patients. J Am Coll Cardiol (1983) 0.92